CAS 103787-97-9

Fórmula: C22H20N2O4S

InChI: InChI=1S/C22H20N2O4S/c1-14-18(23-21(28-14)16-5-3-2-4-6-16)11-12-27-17-9-7-15(8-10-17)13-19-20(25)24-22(26)29-19/h2-10,19H,11-13H2,1H3,(H,24,25,26)

Chave InChI: GUTCYOKMCPFRGH-UHFFFAOYSA-N

SMILES: CC1=C(N=C(O1)C2=CC=CC=C2)CCOC3=CC=C(C=C3)CC4C(=O)NC(=O)S4

BM-131246

CAS: 103787-97-9

BM-131246

Fórmula: C₂₂H₂₀N₂O₄S

Pureza: ≥98%

Peso molecular: 408.47

Ref: 54-BUP20574

BM 131246

CAS: 103787-97-9

BM 131246 is a carnitine palmitoyltransferase inhibitor that has been shown to reduce plasma concentrations of long-chain fatty acids, as well as to improve the symptoms of congestive heart failure. BM 131246 also improves the symptoms of cirrhosis and metabolic disorders such as insulin resistance. This drug may have potential use in the treatment of macrovascular complications of diabetes, including coronary artery disease and peripheral vascular disease. BM 131246 has been shown to produce dose-dependent effects in animals with congestive heart failure, suggesting that it may be used for cardiovascular disorders related to diabetes.

Fórmula: C₂₂H₂₀N₂O₄S

Pureza: Min. 95%

Peso molecular: 408.5 g/mol

Ref: 3D-DEA78797

BM-131246

CAS: 103787-97-9

BM-131246 is an orally available and antidiabetic active thiazolidinedione derivative for the study of diabetes.

Fórmula: C₂₂H₂₀N₂O₄S

Pureza: >99.99%

Cor e Forma: White Solid

Peso molecular: 408.47

Ref: TM-T10561